Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?

Sünnetçioğlu A., Sünnetçioğlu M., Adiyaman F., Binici I., Soyoral L.

CLINICAL RESPIRATORY JOURNAL, cilt.11, sa.6, ss.925-930, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 6
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1111/crj.12438
  • Dergi Adı: CLINICAL RESPIRATORY JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.925-930
  • Anahtar Kelimeler: C reactive protein, leukocyte count, ventilator-associated pneumonia, soluble urine plasminogen kinase activator, C-REACTIVE PROTEIN, ACTIVATOR RECEPTOR, PROGNOSTIC BIOMARKER, CELL COUNT, MORTALITY, CHILDREN, SEPSIS
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

BackgroundSoluble urokinase plasminogen activator receptor (suPAR) is a biomarker that is increasingly used for evaluation of systemic inflammation. This study was performed to investigate whether suPAR may possess a diagnostic value in patients with ventilator-associated pneumonia (VAP).